Topic: Medical: Neurology

The new items published under this topic are as follows.

ANAVEX contracts FORENAP Pharma for clinical trials of ANAVEX 2-73 in Alzheimer


Anavex Life Sciences Corp. has selected FORENAP Pharma EURL as the contract research organization (CRO)
Read full article: 'ANAVEX contracts FORENAP Pharma for clinical trials of ANAVEX 2-73 in Alzheimer'

Posted by  anavex  on  Wednesday, September 30, 2009

ANAVEX completes scale-up manufacturing of ANAVEX 2-73 for Phase I Alzheimer’s


Anavex Life Sciences Corp. today announced the completion of scale-up manufacturing of ANAVEX 2-73, its lead compound for the treatment of Alzheimer’s disease.
Read full article: 'ANAVEX completes scale-up manufacturing of ANAVEX 2-73 for Phase I Alzheimer’s'

Posted by  anavex  on  Monday, September 21, 2009

Educational Seminars That Tie Together Sports with Head/Brain Injuries on LI


LESLIE MUNZER NEUROLOGICAL INSTITUTE OF LI TO PROVIDE EDUCATIONAL SEMINARS FOR ADULTS AND YOUTH THAT TIE TOGETHER SPORTS WITH HEAD/BRAIN INJURIES

March is Traumatic Brain Injury Awareness Month Throughout The United States
Read full article: 'Educational Seminars That Tie Together Sports with Head/Brain Injuries on LI'

Posted by  smmgerica  on  Wednesday, March 25, 2009

Anavex appoints leading Alzheimer's disease expert Dr. Mark Smith to scientific advisory board


Anavex Life Sciences Corp.(OTCBB: AVXL) today announced the appointment of Dr. Mark A. Smith
Read full article: 'Anavex appoints leading Alzheimer's disease expert Dr. Mark Smith to scientific advisory board'

Posted by  anavex  on  Tuesday, February 10, 2009

Anavex Scales Up Synthesis Of Anavex 2-73 For Phase 1 Alzheimer’s Disease Study


Anavex Life Sciences Corp., (“ANAVEX”) (OTCBB: AVXL) has signed an agreement with organic chemistry services provider Syntagon AB (“Syntagon”) for the scale-up manufacturing of ANAVEX 2-73, its lead compound for the treatment of Alzheimer’s disease.
Read full article: 'Anavex Scales Up Synthesis Of Anavex 2-73 For Phase 1 Alzheimer’s Disease Study'

Posted by  anavex  on  Monday, February 02, 2009

Anavex presents potent neuroprotective effects of Anavex 1-41 at Neuroscience 2008


Anavex Life Sciences Corp. ("ANAVEX") (OTCBB: AVXL)was selected to present its latest results with ANAVEX 1-41 at Neuroscience 2008, the 38th annual meeting of the Society for Neuroscience, which took place November 15-19, 2008 in Washington, DC.
Read full article: 'Anavex presents potent neuroprotective effects of Anavex 1-41 at Neuroscience 2008'

Posted by  anavex  on  Friday, December 05, 2008

New Book Shares Real Stories of Coping, Living with Alzheimer’s


Monica Vest Wheeler, an author from central Illinois, announces the release of her new book, “Alzheimer's, Dementia & Memory Loss: Straight Talk for Families & Caregivers.”
Read full article: 'New Book Shares Real Stories of Coping, Living with Alzheimer’s'

Posted by  darcy520  on  Wednesday, July 30, 2008

Radical New Treatment For Cerebral Palsy And Other Developmental Disabilities


June 9, 2008 - A new treatment regime for children with cerebral palsy and other developmental disabilities has been developed by Snowdrop Child Development consultants. The treatment is called ‘neuro-cognitive therapy’ and is presented in the form of a programme, which families carry out at home for several hours per day.

Read full article: 'Radical New Treatment For Cerebral Palsy And Other Developmental Disabilities'

Posted by  brere1  on  Monday, June 09, 2008